GSI 705 (Truvada 167 mg / 250 mg)
Generic Name: emtricitabine/tenofovir
Pill with imprint GSI 705 is Blue, Capsule-shape and has been identified as Truvada 167 mg / 250 mg. It is supplied by Gilead Sciences, Inc..
Truvada is used in the treatment of pre-exposure prophylaxis; nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 705
Truvada
- Generic Name:
- emtricitabine/tenofovir
- Imprint:
- GSI 705
- Strength:
- 167 mg / 250 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- National Drug Code (NDC):
- 61958-0705
More about Truvada (emtricitabine / tenofovir)
- Truvada Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 16 Reviews – Add your own review/rating
- Generic Availability
- Drug class: antiviral combinations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
